ANISSA PERRIN: Open Payments
NPI 1871924571 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 106 payments from 19 companies in 2025. Trend: 2023 $1,492 · 2024 $2,193 · 2025 $2,525
Food & beverage: $2,525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $617 |
| Janssen Biotech, Inc. | 14 | $343 |
| UCB, Inc. | 8 | $323 |
| Regeneron Healthcare Solutions, Inc. | 9 | $304 |
| Novartis Pharmaceuticals Corporation | 20 | $258 |
| Galderma Laboratories, L.P. | 13 | $203 |
| Organon LLC | 3 | $74 |
| GENZYME CORPORATION | 2 | $71 |
| Lilly USA, LLC | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Bimzelx, COSENTYX, RINVOQ, NEMLUVIO, VTAMA.
Industry payments across PA — which companies pay providers there.
